uniQure N.V. financial data

Symbol
QURE on Nasdaq
Industry
Pharmaceutical Preparations
Location
Paasheuvelweg 25 A, Amsterdam, Netherlands
Fiscal year end
December 31
Former names
uniQure B.V. (to 2/6/2014)
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 798 % -6.04%
Quick Ratio 16.6 % +97.4%
Debt-to-equity 487 % +349%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.7M shares +1.95%
Common Stock, Shares, Outstanding 48.7M shares +1.94%
Entity Public Float 547M USD -37.2%
Common Stock, Value, Issued 2.93M USD +1.7%
Weighted Average Number of Shares Outstanding, Basic 48.7M shares +1.99%
Weighted Average Number of Shares Outstanding, Diluted 48.7M shares +1.99%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 148M USD -36%
Costs and Expenses 233M USD -25.5%
Operating Income (Loss) -200M USD -2.87%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -235M USD -2.22%
Income Tax Expense (Benefit) 4.61M USD +55.1%
Earnings Per Share, Basic -4.95 USD/shares -3.13%
Earnings Per Share, Diluted -4.95 USD/shares -3.13%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 252M USD +9.65%
Inventory, Net 7.67M USD +2.61%
Assets, Current 464M USD -33.1%
Deferred Income Tax Assets, Net 10.9M USD -12%
Property, Plant and Equipment, Net 25.6M USD -44.4%
Operating Lease, Right-of-Use Asset 14.8M USD -51.1%
Intangible Assets, Net (Excluding Goodwill) 60.5M USD +2.9%
Goodwill 24.1M USD -4.71%
Other Assets, Noncurrent 1.45M USD -75.9%
Assets 646M USD -25.9%
Accounts Payable, Current 5.44M USD -2.56%
Employee-related Liabilities, Current 15.4M USD -4.96%
Accrued Liabilities, Current 32.3M USD +13.6%
Liabilities, Current 71.3M USD +3.89%
Deferred Income Tax Liabilities, Net 7.63M USD +55.1%
Operating Lease, Liability, Noncurrent 12.2M USD -57.9%
Other Liabilities, Noncurrent 8.92M USD +716%
Liabilities 590M USD -2.12%
Accumulated Other Comprehensive Income (Loss), Net of Tax -56.7M USD +3.18%
Retained Earnings (Accumulated Deficit) -1.06B USD -29.3%
Stockholders' Equity Attributable to Parent 55.8M USD -79.2%
Liabilities and Equity 646M USD -25.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -60.6M USD +22.6%
Net Cash Provided by (Used in) Financing Activities 131K USD -73%
Net Cash Provided by (Used in) Investing Activities 64M USD +2041%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 48.7M shares +1.94%
Common Stock, Par or Stated Value Per Share 0.05 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.69M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 253M USD +8.79%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.76M USD +55.7%
Deferred Tax Assets, Valuation Allowance 145M USD +94.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.26 pure 0%
Deferred Tax Assets, Gross 174M USD +65.5%
Operating Lease, Liability 36.7M USD -8.58%
Payments to Acquire Property, Plant, and Equipment 2.34M USD +0.09%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -238M USD -22.5%
Lessee, Operating Lease, Liability, to be Paid 49.9M USD -13%
Property, Plant and Equipment, Gross 102M USD +7.99%
Operating Lease, Liability, Current 4.3M USD -45.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.21M USD +8.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.37M USD -0.17%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) -1.21M USD -95.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.3M USD -23.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.33M USD +4.74%
Deferred Tax Assets, Operating Loss Carryforwards 146M USD +72.3%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.27M USD +1.71%
Additional Paid in Capital 1.17B USD +2.16%
Deferred Tax Assets, Net of Valuation Allowance 29M USD -5.5%
Interest Expense 54.1M USD +324%